User's Manual

Table Of Contents
Ensure PTM is enabled. If desired, ensure that Patient Triggered Monitor is enabled prior to sending
the patient home by conrming the Magnet Response is programmed to Store EGM. If the feature is
inadvertently left in the Inhibit Therapy setting, the patient could potentially disable tachyarrhythmia
detection and therapy.
Magnet Response set to Inh ibit Therapy. Once the P atient Triggered Monitor feature has been
triggered by the magnet and an EGM has been stored, or after 60 days have elapsed from the day
that Store EGM was enabled, the Magnet Response programming automatically will be set to Inhibit
Therapy. When this happens, the patient should not apply the magnet because tachyarrhythmia therapy
could be inhibited.
PRECAUTIONS
Clinical Considerations
Pacemaker-mediated tachycardia (PMT). Programming minimum PVA RP less than retrograde V–A
conduction may increase the likelihood of a PMT.
Sterilization and Storage
If package is damaged. The blister trays and contents are sterilized with ethylene oxide gas before
nal packaging. When the pulse generator and/or lead is received, it is sterile provided the container is
intact. If the packaging is wet, punctured, opened, or otherwise damaged, return the pulse generator
and/or lead to Boston Scientic.
If device is dropped. Do not implant a device which has been dropped while outside of its intact shelf
package. Do not implant a device which has been dropped from a height of more than 24 inches (61 cm)
while within its intact shelf package. Sterility, integrity and/or function cannot be guaranteed under these
conditions and the device should be returned to Boston Scientic for inspection.
7